AUTOIMMUNE DISEASES CAUSED BY AN INFECTION?

From Combating Biofilms: The Reason Many Diseases Do Not Respond To Treatment

Xylitol

Xylitol has a long history of use to decrease dental plaque in alternative medicine. In one powerful study, xylitol gum that was used for 39 months was still limiting dental plaque and altering mouth bacteria 15 months after it was stopped. However, it may be likely that new alternative medication solutions, if not used wisely, could lead to the pool algae I mentioned that laughed at chlorine. And while xylitol is a useful biofilm tool, it is possible some bacteria are developing resistance. Further, while newer studies still point to an effect on “lowering biofilm mass” (Alves), and reporting its effect in complex dental procedures, it is very likely this is not the only way or even the primary way this sugar undermines infections. Xylitol was also found to be very useful in lab evaluation for use with wounds. Simply, the more xylitol used, the better the effect. The sugar was tested on a simulation of very tough wound infections that make biofilms: Pseudomonas aeruginosa, Enterococcus faecalis and Staphylococcus aureus. These are three of the most important species associated with biofilms. Biofilm formation was completely inhibited with treatment of 20% xylitol (Dowd). Xylitol’s effects are not limited to oral mouth health. In a summary article it was accepted that in clinical trials, xylitol decreased the occurrence of acute otitis media in day-care children—a common problem for children. Obviously this shows benefits in another organ outside the mouth. Another comment in this study may be of use in lifestyle health. Let me quote: “Exposure to xylitol lowered [biofilm marker] values…but when the [lab bacteria growth substance or] medium was supplemented with glucose or fructose, biofilm formation was enhanced and the inhibitory effect of xylitol on biofilm formation was not observed.” The impression I have is that glucose and fructose are the two most common sugars consumed by humans in the developed world. So in cases of ear infections caused by Strep, pneumonia or throat infections, it is possible that dietary restrictions of “high access” sugars like sucrose, and fructose found in fruit juice can aid in lowering biofilm. I suspect corn syrup would also be a problem. I do not know if the slow release of fructose such as eating an apple or pear would make xylitol useless. While this is a lab study, I think that the finding that routine dietary sugars helping biofilm formation and undermining a useful treatment should be noted.

Erythritol

Erythritol Erythritol is an amazing sugar. For example, when it was given to children head-to-head with xylitol or sorbitol it was clearly superior. Here is a summary of the research: Runnel writes: “Three-year consumption of erythritol-containing candies by initially 7- to 8-year old children was associated with reduced plaque growth, lower levels of plaque acetic acid and propionic acid, and reduced oral counts of mutans streptococci compared with the consumption of xylitol or sorbitol candies.” In a similar way, Japanese researchers show highly advanced reasons for erythritol superiority over xylitol and sorbitol (Hashino). While this study is very dense, let me at least try to list the stunning findings: By advanced confocal microscopic observations, the most effective sugar used to reduce P. gingivalis accumulation onto an S. gordonii substratum was erythritol, as compared with xylitol and sorbitol. In addition, erythritol moderately suppressed S. gordonii monotypic biofilm formation. To examine the inhibitory effects of erythritol, they analyzed the metabolomic profiles of erythritol-treated P. gingivalis and S. gordonii cells. Metabolome analyses showed that a number of critical bacteria chemicals were decreased by erythritol.

Next, metabolites of erythritol- and sorbitol-treated cells were examined. Erythritol significantly decreased the levels of P. gingivalis dipeptides. They tended to be increased by sorbitol. Amazingly, it appears erythritol has inhibitory effects on two diverse species with biofilms, and it acts by at least five very distinct mechanisms. Dowd reported that biofilm formation was completely inhibited in a standard wound approach by 10% erythritol in either of the two Sanguitec gel formulations. Erythritol had an inhibitory effect on P. aeruginosa and S. aureus growth at over 5% concentrations.


Silver

Silver Silver treatment used against the biofilms in wounds has clearly been effective. Indeed, a 1% silver cream has been used successfully to treat and prevent infections in burn patients all over the world. A review by the International Wound Infection Institute shows the data still points to silver as a top treatment. For example, Monteiro tested colloidal silver against fungal biofilms. The conclusion of that work is very firm: irrespective of concentrations used in the study, silver affected the matrix composition and structure of Candida biofilms.

Ionic silver was found to be markedly useful. Silver alginate and silver carboxymethyl cellulose (SCMC) dressings were used on wound infections of challenging bacteria in burn victims. Both dressings at high and low pH helped defeat all of these bacteria: vancomycin-resistant Enterococcus faecium methicillin-resistant Staphylococcus aureus (MRSA) multidrug-resistant Pseudomonas aeruginosa multidrug-resistant Vibrio species multidrug-resistant Stenotrophomonas maltophilia.

The use of ionic silver (Ag+) in a silver nitrate salt (AgNO3) had profound antimicrobial activity against Escherichia coli. Silver or Ag+ appeared to induce OH- production and increase membrane permeability (Morones-Ramirez). The possible mechanisms also include: disruption of normal bacterial cellular reactions disulfide bond damage metabolism interference iron balance disruption increased reactive oxygen chemicals increased cell membrane permeability (Percival)

In mice and in the lab (in vitro), silver appeared to increase the activity of and potentially restore antibiotic susceptibility to antibiotic-resistant bacteria. For example, silver treatment of hardy bacteria in mice, as well as lab-generated biofilms, expanded the antibacterial capacities of vancomycin. Finally, both in vitro biofilms and biofilm infections in mice were made more vulnerable to destruction by silver (Morones-Ramirez 2013).

Aspirin

Another useful way to involve aspirin is by teaming it up with the chelation chemical EDTA. Both aspirin and EDTA possess broad antimicrobial activity for biofilm cultures. Aspirin used for 24 hours was successful in eradicating P. aeruginosa, E. coli and C. albicans biofilms. Moreover, exposure to the Aspirin-EDTA combination completely destroyed bacterial biofilms after only four hours in simulation lab testing (Al-Bakri).


Serrapeptidase

Looking at serrapeptidase with more of a scientific eye, Papa’s team recently found this enzyme “could be developed as a potential ‘anti-infective agent’ able to hinder the entry of S. aureus into human tissues, and also impair the ability of this pathogen to adhere to prostheses, catheters and medical devices.” Based on an examination of the biofilm-making Staphylococcus aureus found on most people and in hospitals, we know it has many cell surface survival factors, including proteins that promote adhesion to damaged tissue and to the surface of victim cells, and that bind proteins in blood to help evade immune responses. Serrapeptidase appears to undermine one or more of these processes.
 
I just watched another video from May 2015 by Dr. Kleinhardt. It's got more up to date information. He doesn't talk about biofilms, but two things of interest, chlorella and liposomal melatonin. He says that the brain cells shrink to 40% of their size during sleep so that the fluids can carry away toxins. He says that melatonin is 9 times more important in detoxing the brain than glutathione. He also has statistics regarding chlorella used by pregnant mothers and that the autism rate of their children dropped to 1 in 10,000, compared to 1 in 35 in the UK and US because of its ability to carry away the heavy metal loads in the mother. He says 2/3 of a mother's mercury load is passed to the first child. Pretty scary stuff. It's really packed with information. He also talks about the effects of EMF. He refers to slides but they're not shown in the video.

_https://www.youtube.com/watch?v=U7eT_grJKNc
 
A recent article with a medical chemist:-

"Resistance Isn't Futile - How To Tackle Drug-resistant Superbugs. Low profit margins and the difficulty of finding new drugs has led to big pharma shutting down its antibiotics programmes. But now researchers are adopting new approaches to tackle drug-resistant superbugs."

"www.theguardian.com/science/2015/jul/19/antibiotics-new-research-end-of-drug-resistant-superbugs"
 
One more good Klinghardt interview with Mercola:


I tried to note topics that either haven't been touched on in other interviews posted so far, or that are treated more in-depth in this one. The points are in sequence, and I noted approximate times on a few of the topics I thought people might be particularly interested in:

• Illnesses once thought to be caused by toxicity are now being found to be caused by chronic infection
• Lyme disease is an illness carried by insects: ticks, mosquitoes, spiders, fleas, mites
• Sequences in human genome come from insect, bacterial, and viral genomes
• Bioweapon experiments (7:00)
• Order of infection: Primary infections; coinfections, which in turn trigger mycoplasma; parasites (protozoa, worms)
• Rheumatoid Arthritis/Lyme disease connection (16:00)
• Cell-wall deficient forms (30:00)
• Priority of treatment: Mold, EMF, Trauma history
• Microbes in the brain prevent higher psychological work – treatment needs to happen first, then relationship issues can be addressed
• Antibiotics work will up to a point, but you reach a plateau that is hard to move beyond (51:00)
Klinghardt Lyme cocktail and lungworm cocktail (lungworm commonly found in dogs)
• Virii need to be treated indirectly (1:01)
• Insulin resistance is induced by Lyme disease (1:02); can be treated with niacinamide, berberin (niacin/niacinamide are both antimicrobial)
• Doesn’t want to poo-poo antibitotics (1:10) – recommends taking a look at ILADS.org. But going beyond antibiotics is often beneficial.
• Discussion of safety of long-term antibiotic protocols.
• Discussion of making and benefits of liposomal products

There's also a short discussion of the war on Rife technology in this part of an earlier Mercola video (at about 4:00):

 
nicklebleu said:
I had a look if turpentine was any help in resolving the biofilm issue - and apparently there is. However there is very little in the medical literature about turpentine, for obvious reasons. But some alternative health providers advertise the ingestion of turpentine as part of a candida protocol (this has been talked about here on the forum before). So it might be work including turpentine on the protocol in view of disrupting biofilms.

While sifting through the data I ran across a paper describing hepcidine, which is quite fascinating. Hepcidine has been talked about in this thread earlier on as well.

<snip>

Source including free full-text

Can you list for me the take home elements of this paper? Are they saying that an injection of turpentine is helpful?
 
Shijing said:
One more good Klinghardt interview with Mercola:

{...}

I tried to note topics that either haven't been touched on in other interviews posted so far, or that are treated more in-depth in this one. The points are in sequence, and I noted approximate times on a few of the topics I thought people might be particularly interested in:

• Illnesses once thought to be caused by toxicity are now being found to be caused by chronic infection
• Lyme disease is an illness carried by insects: ticks, mosquitoes, spiders, fleas, mites
• Sequences in human genome come from insect, bacterial, and viral genomes
• Bioweapon experiments (7:00)
• Order of infection: Primary infections; coinfections, which in turn trigger mycoplasma; parasites (protozoa, worms)
• Rheumatoid Arthritis/Lyme disease connection (16:00)
• Cell-wall deficient forms (30:00)
• Priority of treatment: Mold, EMF, Trauma history
• Microbes in the brain prevent higher psychological work – treatment needs to happen first, then relationship issues can be addressed
• Antibiotics work will up to a point, but you reach a plateau that is hard to move beyond (51:00)
Klinghardt Lyme cocktail and lungworm cocktail (lungworm commonly found in dogs)
• Virii need to be treated indirectly (1:01)
• Insulin resistance is induced by Lyme disease (1:02); can be treated with niacinamide, berberin (niacin/niacinamide are both antimicrobial)
• Doesn’t want to poo-poo antibitotics (1:10) – recommends taking a look at ILADS.org. But going beyond antibiotics is often beneficial.
• Discussion of safety of long-term antibiotic protocols.
• Discussion of making and benefits of liposomal products

Thanks Shijing, that's a very interesting interview indeed. I listened to to 53 minutes so far and stopped when he's about to get into the treatment itself. I made a few notes using bits of your notes, in case they are useful for the document and follow up.

- Lyme disease: Many people claim that most people have it or had it in one way or another, but only some have the symptoms. It can be carried by insects: ticks, mosquitoes, spiders, fleas, mites.

- Illnesses once thought to be caused by toxicity are now being found to be caused by chronic infection. They are part of evolution. Sometimes something good comes out of it. Bright people with infections, illness can contribute to creativity. Sequences in human genome come from insect, bacterial, and viral genomes as an evolutionary interaction from which something good may come up, but that's not the case usually.

- Bioweapon experiments: Government documents> Experimenting with recombining microbes in order to create stealthy microbes that make large populations ill, so they loose the will to fight. Some forms of Lyme disease might be part of these experiments. The microbe and illness expressions look very different in Europe.

- There are records in history, but something happened 30 or 40 years ago when the bugs became more aggressive, more penetrating, more illness producing. He suspects EMF exposure is making them more aggressive.

- Common symptoms and testing: Large spectrum of illness

> Lyme and co-infections: underneath Lyme there is mycoplasma infection.
> Opportunistic infections: Compromised immune systems trigger different forms of parasites (protozoa, worms).

* Joint pain. Ozone is effective.
* Connective tissues> Fibromialgia. Pain in the body.
* Immunological expressions> Autoimmune disease has an underlying level of Lyme disease.
* Gastroenterological expressions> Digestive problems.
* Neurological expressions.

> The white cells are affected by Lyme so they loose the ability to produce antibodies, which undermines the usual antibodies testing. Treat the patient first so that he/she can make immune response and then test. They do an autonomic response testing> Reflex connected to different diseases. After 6 weeks of treatment, they do the blood/microscopy test.

> Indirect test: CD57- One group of killer cells particularly affected by Lyme disease. (CD57 antigen (CD stands for cluster of differentiation) is a carbohydrate which is also called HNK1 (human natural killer-1) or LEU7.)

General guideline

* Over 100> OK.
* Under 100> infection with borrelia.
* Under 60> infection with borrelia plus mycoplasma and most likely other co-infections.

They start as low as 7 or 9 and gradually go up after treatment. They monitor this afterwards every six months or so in case of relapse.

- Microbes penetrating cells. They give up their walls in order to live in the intracellular environment. He believes that these bug have been with us for a very long time, and what has changed is the interaction with external factors... again, EMF is crucial according to him> One big part of his treatment is protecting oneself from it.> What's driving the microbes nuts? > Mutation and co-infections.

- Priority of treatment:

> External factors:

* Molds- Mold testing at home. Huge contributor to Lyme symptoms. There are over 600 pathogenic molds. Moisture intrusion into the home (leaks, for example) / survingmold.com

* EMF- Mold gets more virulent from EMF exposure. Measure microwaves in the home. Shielding the home Y-shield, Curtains that serve as shield. At least the bedroom. Phones that only broadcast only when there's an incoming calls. There are more instructions and tips in mercola.com (and SOTT.net). Switch off electric things at night.

Mercola says is a good strategy for everyone, not just Lyme disease patients. Klinghardt says that the patients who do these two things generally have a better outcome in treatment.

> Trauma history:

* Psychokinesiology.
* Psychological treatment: Microbes in the brain prevent higher psychological work – treatment needs to happen first, then relationship issues can be addressed

I'll watch the rest later, and I'm sorry if the spelling of some difficult words isn't correct. :-[

Fwiw...
 
LQB said:
Laura said:
LQB said:
Yesterday there was about an hour of hot fever-like condition accompanied with nausea, more gas, and general malaise/low energy - all unusual for me.

VERY promising! Sounds like you are getting some action!

I think so too since nothing else has changed (like diet, environment, etc).

Excess gas continued for a while but appears over now. No detectable reactions over the last two days. One thing I have noticed is considerably less lower-right back pain after long periods of reading (sitting on the couch).

I started this experiment with the practitioner without any major complaints or chronic conditions to investigate.

It may be that efficacy of some of these machines depends on conditions associated with both the patient and the practitioner. If true, they will likely never be scientifically validated under current paradigms.
 
As many others wrote: what a topic and what a development and thanks for the effort in presenting these many links and studies!! It was interesting that many topics got picked up where I had similar thoughts, for example about iron and hemochromatosis. I continue reading some papers of the topic and two books are also already ordered, one about that Shijing mentioned (Infectious Diabetes) at the very beginning and of course Plague Time. Then I will see if I can start such an experiment too or not also when the main thought is how it is possible following such a harsh protocol when I have to go to work. But till then maybe other or better solutions may be found and if not I'm also using the nuke therapy ;).
 
Yas said:
I made a few notes using bits of your notes, in case they are useful for the document and follow up.

Thanks, Yas -- I appreciate your doing that, since I'm not always able to reproduce as much information as I'd like to from some of the videos. Thanks also to Altair for posting the excerpts from Combating Biofilms -- I only have the hard copy, but it's easier to extract specific sections if you're working with the electronic version.
 
I posted this in the 18 July session:

Just had the word ‘berries’ jump to mind as discussed in the March 14 2015 session as I was reading and did a quick search on the antiparasitic qualities of berries and come up with this:

Antiparasitic, Nematicidal and Antifouling Constituents from Juniperus Berries

http://www.dochterland.org/juniperus.pdf

https://en.wikipedia.org/wiki/Juniper_berry

Edited to add link.

Then there is this:

http://www.blueberry.org/research1/antibacterial/Antibacterial_Annotated.htm


The berry thing from the March session is still bugging me.

I wondered if biofilms are weaker in some seasons. It makes sense that they would need to be since in order for an infection to spread throughout the body, then at some stage the bugs have to get out from behind the biofilm to spread and this would be a time where the integrity of the biofilm is compromised. Since March is the beginning of spring in the northern hemisphere, and this is also the time that berries appear, and it's also curious that berry's were mentioned in a spring session. There is also the fact that many carnivores eat berries. So maybe it's part of the natural design that berries are around at the time when the biofilm is weaker. There seems to be a bit of information around on seasonal weakness in biofilms in the natural environment - water/river systems for example, but none that I've found so far in the internal environment of a person. But I can't see why it wouldn't be the case.

Also, the antioxidant properties of berries may reduce or mitigate symptoms of the herxheimer reactions.

I don't have the resources at the moment to commit to looking into this in more depth, but find the connections interesting none the less.
 
I was reading about herx reations because I think I'm having one after taking water kefir and I've found that Serrapeptase is useful and that it also enhaces antibiotic treatments.

It has been mentioned a few times in the thread but with no addition information, so here's an article that I've found on the subject, concerning Lyme disease:

Serrapeptase is a relatively new ‘rising star’ enzyme on its way to becoming one of the biggest enzyme of all time. It was discovered in the early 70’s and is now in wide use throughout Europe and Asia as an anti-inflammatory and fibrin dissolver for 25 years.

Serrapeptase was originally found in the silkworm where it is a part of the silkworm’s body chemistry. The silkworm has a special relationship with microorganisms. The enzymes secreted by the bacteria in silkworm intestines have the ability to dissolve the cocoon tissue. The silkworm uses this enzyme to dissolve its protective cocoon, so the winged creature is able to emerge and fly away. Obviously, if it can dissolve a cocoon proteins, we have an interest in it dissolving Lyme cysts and biofilms. (1)

Sure enough, studies have found this enzyme to be very effective at dissolving non-living tissue, especially internal scar tissue, lesions and our favorite: fibrin biofilms! Yes, serrapeptase is also a good partner with nattokinsae and the other enzymes in dissolving the fibrin in blood clots, cysts, and arterial plaque. The uses are wide ranging and cover just about every condition that is affected by inflammation scar tissue, fibrin and/or non-living tissue.

For 25 years, Serrapeptase has been studied and is used worldwide to help numerous medical conditions including arthritis, asthma, bronchitis, cardiovascular disease, to name a few. It has been used to:

- Dissolves the biofilms coating microbes like Lyme and for autism.
- Allow the bacterial colonies hiding behind biofilms to be destroyed.
- Dissolve the fibrin in biofilm walls.
- Help reduce inflammation,
- Help dissolve any fibrin in arterial plaque.

One of the significant advantages of Serrapeptase is that it does not affect the cells or tissues in the human body in good condition. As we said, studies show it dissolves only non-living tissues such as cysts and biofilms. (2)

Hans Nieper is a German doctor known for his treatment of atherosclerosis. He named serrapeptase a "miracle enzyme" after using ultrasound to measure its ability to dissolve arterial plaque without affecting cells! Serrapeptase is a proteolytic enzyme that offers safe but powerful anti-inflammatory properties and fibrin busting ability.(3)

Serrapeptase is also used as a natural alternative to aspirin (salicylates), Ibuprofen and the more potent NSAIDs drugs - without all their nasty side effects! Unlike these drugs, serrapeptase is a naturally occurring enzyme with no hindering effects on prostaglandins and no gastrointestinal side effects.

A study in Italy disclosed 91% of those taking serrapeptase reported good to excellent results compared to 22% in the control subjects.(4) Knee cartilage operations were followed by 50% less swelling in the group of patients taking serrapeptase.(5) Twenty patients with carpal tunnel syndrome were given 10 mg of serrapeptase twice daily. Thirteen of these were better with electrophysiologic proof of recovery.(6)

It even crosses the blood brain barrier!

Important for Lyme Co-Infections.

Over the past 30 years, studies and practitioners’ observations have shown benefits in a huge range of conditions including:

Arthritis, Inflammatory Migraines,
Bronchitis, Asthma,
Bronchiectasis, Sinus,
Blocked Arteries, Fibrocystic Breast Disease,

Studies even claim that nothing surpasses the ability of serrapeptase to safely stop inappropriate chronic inflammation its tracks. No matter the cause or the location, serrapeptase helps stop inflammation and dissolves fibrin biofilm tissue.(7)

Fibrin Activity and Scar Tissue Removal

Another feature that studies point out is that one of the most significant features of serrapeptase is that it does not harm any living cells or tissues in the human body. We love it because it only dissolves non-living fibrin tissue including cysts and biofilms, scar tissue, mucous membrane, necrotic tissue, embolisms, and arterial plaque.(8) These same qualities make it equally effective in dissolving problem tissues in the human body.

Serrapeptase digests non-living tissue, blood clots, cysts, and arterial plaque and inflammation in all forms. However, probably the most important aspect of serrapeptase is its fibrinolytic activity (it dissolves fibrin)! For the treatment of Lyme disease, Dr. Lee Cowden now uses Serrapeptase to dissolve the fibrin layer surrounding the bacteria.(9) This layer is associated with Lyme disease such as Borrelia, Babesia, Bartonella and Ehrlichia.

Studies conducted in Europe and Asia have shown that Serrapeptase is an effective fibrinolytic and it is this fibrin activity that is of particular interest to us. Improper build-up of fibrin becomes a significant risk factor for bacterial infectious diseases.

Serrapeptase also appears to help dissolve scar tissue. One study showed 65% of carpal tunnel patients showed significant clinical improvement. No significant side effects were observed. The doctors concluded that serrapeptase therapy may prove to be a useful alternative conservative treatment.(10)

A double-blind study of a group with cystic breast disease were given serrapeptase. Over 85% of the patients receiving serrapeptase reporting moderate to marked improvement. This encourages the use of serrapeptase enzymes to help reduce the fibrin biofilms and cysts of Lyme disease and other infections. Serrapeptase induces fragmentation of fibrin aggregates thereby promoting the tissue repair process. (No adverse reactions were reported with the use of serrapeptase.)

Pain

Probably because of reducing inflammation and dissolving fibrin, one of serrapeptase's most profound benefits appears to be a reduction of pain! This is due to its ability to block the release of pain-inducing amines from inflamed tissues. It reduces inflammation in three ways:

1. It breaks down the insoluble protein by-products of blood coagulation known as fibrin;
2. It thins the fluids formed form inflammation and injury,
3. It facilitates their drainage which speeds the tissue repair process.

A study was conducted on the effect of serrapeptase on post-operative swelling and pain of the ankle. In the serrapeptase group, the swelling decreased by 50% on the third post-operative day, while in the control groups no reduction in swelling occurred. A decrease in pain correlated for the most part with the reduction in swelling. On the basis of these results, serrapeptase would appear to be an effective preparation for the post-operative reduction of swelling, in comparison with the classical conservative measures, for example, the application of ice.(11)

Lyme Disease

Of course, we have a special interest in how serrapeptase can help make our Monolaurin more effective in dealing with Lyme disease. We know from many, many studies that monolaurin kills Lyme bacteria when it can come into contact with it. It appears to be able to do this even with light fibrin biofilm coatings. However, the biofilms can slow it down and it won't penetrate heavy biofilms or Lyme cysts. The speed and efficiency of monolaurin can be increased with the help of these enzymes.

The fibrin layer covering Lyme co-infection microbes may even cause them to be hidden from the immune system. When using serrapeptase, once the fibrin is dissolved, the immune system can more easily identify fight the harmful microbes. With our Monolaurin, the job is even faster and more complete!

Herxheimer Reactions

At a recent seminar, medical practitioners were shown how silkworm serrapeptase and other enzymes were able to break up slimy biofilms and uncover hidden Lyme disease bacteria. These special enzymes dissolve protective biofilms and enable medications, herbs, and the immune system to more effectively kill hidden germs.

When the biofilms are dissolved, our Monolaurin can get to the bacteria to kill them. However, while dissolving the biobilms and Lyme cysts is essential to solving Lyme disease, it can also release some toxins within them. This can cause a temporary increase in discomfort until the liver, kidneys and skin filters out the toxins. (Our Body Detox is often used to help minimize discomfort by capturing and removing toxins.)

Special Capsules for Intestinal Absorption

Of course, to achieve an ideal therapeutic effect, it is essential that any enzyme preparation can be efficiently absorbed. When consumed in unprotected tablets or capsules, enzymes are often destroyed by acid in the stomach. However, our special capsules enable the enzyme to pass through the stomach unchanged, and be absorbed in the intestine. This releases the enzymes in the intestines (where they can be absorbed), not in the stomach (where they can be neutralized).

Several research groups have reported that serrapeptase is well absorbed orally when formulated with the ability to bypass the stomach. It is known that proteases and peptidases are only absorbed in the intestinal area. These enzymes are mobilized directly to the blood and are not easily detectible in urine. Other enzymes with structural similarities have been reported to be absorbed through the intestinal tract.

Serrapeptase is classified as a systemic enzyme (directly absorbed from intestine into the blood stream). Research confirms that serrapeptase is absorbed into the circulation in its active form.(1) Since in-vitro and in-vivo studies, including controlled studies, reveal that serrapeptase has a superior effect to that of other proteolytic enzymes, it makes serrapeptase is useful for a broad range of inflammatory and fibrin conditions.

Dosage

Many of the experimental therapeutic daily dosages were about 30,000 – 40,000 iu daily. Why do we use more? The answer is simply because we have found it works better! In years of higher doses given by many experimenters, there have been no reports of any side effects from these doses except for a few people that had a pre-existing dysfunctional digestive tract.

Serrapeptase does not have a current upper limit for standard dosages. In fact, many physicians report that extra dosages are helpful in most cases (though we prefer to go slower with Lyme disease to help prevent herx reactions). They usually tell their patients to take the medication at least 45 minutes prior to eating, or 1 hour after eating, in order to avoid any possible protein interference (as we do also).

Some people report that they see more improvement in their conditions after the first few weeks. Skipping dosages can lead to fewer positive results.

Once again, the efficacy of serrapeptase was evaluated in a multicentre, double-blind, placebo-controlled study of 193 subjects. It was concluded that serrapeptase has anti-inflammatory, anti-edemic and anti-fibrin activity. (4)

Clearly, the potential applications for serrapeptase are many and varied. Whether the application is fibrinolytic, anti-inflammatory, analgesic, antibacterial, a mucolytic expectorant, as well as others, serrapeptase is the cutting edge in systemic enzyme therapy.

Combined with the other enzymes in our Bio-Fibrin and monolaurin, it makes a great team!

_http://www.inspirednutrition.com/bio-fibrin-enzymes-serrapeptase.html

Well, they are selling a product there, but there are lots of references that can be used for further reading.
 
Laura said:
nicklebleu said:
I had a look if turpentine was any help in resolving the biofilm issue - and apparently there is. However there is very little in the medical literature about turpentine, for obvious reasons. But some alternative health providers advertise the ingestion of turpentine as part of a candida protocol (this has been talked about here on the forum before). So it might be work including turpentine on the protocol in view of disrupting biofilms.

While sifting through the data I ran across a paper describing hepcidine, which is quite fascinating. Hepcidine has been talked about in this thread earlier on as well.

<snip>

Source including free full-text

Can you list for me the take home elements of this paper? Are they saying that an injection of turpentine is helpful?

Sorry, I wasn't very precise - there is a bit of a thought leap involved.

I stumbled over this paper while I was searching for turpentine in PubMed.

But oral ingestion and injection of turpentine seem two totally different things. While oral turpentine apparently disrupts biofilms and kills critters in the gut, injected turpentine causes a massive local inflammation. So while the first probably is beneficial, the latter certainly isn't.

I published the paper not for the turpentine content (which was coincidental), but regarding hepcidine, which was mentioned earlier on in the thread.

Hope that clears it up - don't inject turps.
 
Camel's Milk - here is a link to a few photos of Jebalis (translation - mountain men) who live in the Dhofar region of Oman.
The jebali man commonly has around 200 camels for his extended family. They herd them through the mountainous deserts looking for grazing on a constant basis. These are truly nomadic people. I would often see a Jebali striding barefoot down the street in Salalah, with his rifle slung over his shoulder and ammunition belt round his waist. One time I could swear this Jebali must have been 90 years old, but his body was hard as nails, and he had not one ounce of fat of him, briskly striding along. My Omani friend said he had at least 200 camels waiting for him on the mountains. The nomadic people existed for the most part on nothing but camels milk. Maybe once a year, as a celebration they would kill a cow bought from market. But eating meat was a rarity. We were often invited to drink raw camel's milk - but I didn't realise it's benefits then and was appalled that they expected me to drink it raw, without being pasteurised.
There are still tribes of Jebalis in Dhofar, existing this way.

_http://www-old.sant.ox.ac.uk/mec/mecaphotos-butt-oman-people.html
 
A little addition to my previous post: that documentary also features Dr. Klinghardt, who's ideas have so far appeared quite good.

And, there seems to be a sequel to it, too:

UNDER OUR SKIN 2: EMERGENCE

Trailer:


Published on 11 May 2015
The acclaimed documentary UNDER OUR SKIN (2009) brought unprecedented awareness to the shocking story of Lyme disease, an often-chronic condition many doctors claimed was “all in your head." Since then the CDC has upped its estimate of annual cases by ten times, making Lyme disease more prevalent than HIV and breast cancer combined. This highly-anticipated sequel, UNDER OUR SKIN 2: EMERGENCE, investigates the deepening Lyme disease crisis and follows its casualties and controversies. As the Lyme epidemic explodes globally, scandalous medical collusions and conflicts of interest incriminate the very healthcare systems meant to protect us. Despite the obstacles that researchers, physicians and patients continue to face, promising new findings are emerging. And when we revisit the once gravely ill characters from UNDER OUR SKIN, we see that they have moved from horror to hope, arriving at better health and reclaiming their lives.

You can find the whole movie on YouTube, but it seems that you have to pay a few dollars to watch it:
https://youtu.be/IY5LQfOJsus

At least from the trailer, it looks like this one lady got better (her talking is completely normal now)!
 
Back
Top Bottom